Asafo & Co. advised Laprophan SA on the deal. Laprophan SA, a leading Moroccan pharmaceuticals group, completed the acquisition of Amanys Pharma from SPE Capital and Proparco....
Laprophan’s Acquisition of Amanys Pharma
Mediterrania Capital Partners’ Investment in Cash Plus
Asafo & Co. advised Mediterrania Capital Partners on the deal. MCP completed a €57 million investment in Cash Plus in partnership with the FMO, the Dutch...
Laprophan SA’s Joint Venture Agreement with the MAScIR Foundation
Asafo & Co. advised Laprophan SA on the deal. Laprophan SA signed a joint venture agreement with the MAScIR Foundation to develop innovative biomedical technology healthcare...